Sarcoma News

Five-year survival for the most common 18 cancers remained highest globally for the United States, Canada, Australia and New Zealand, followed by Finland, Iceland, Norway and Sweden, according to data through 2014 from CONCORD-3.

Older people living with HIV remain at an elevated risk for cancer, according to findings published in Clinical Infectious Diseases.

A clinical trial is underway to assess use of two immunotherapy agents, durvalumab and tremelimumab, plus radiation therapy for the treatment of newly diagnosed high-risk sarcoma.

Mohamad Cherry, MD, has joined Atlantic Health System’s Atlantic Medical Group.

Five ASCO members have been elected to the society’s board of directors to fill existing vacancies.

Howard A. “Skip” Burris III, MD, FACP, FASCO, has been elected to serve as president of ASCO for the 2019-2020 term.

The top stories in hematology and oncology this year included articles on study results published in peer-reviewed journals, FDA approvals and practice-changing data presented at scientific meetings, as well as articles that featured interviews with leading researchers and expert opinions on approaches to patient care.

J. William Charboneau, M D, received the 2017 Gold Medal from the Radiological Society of North America.

States with expanded Medicaid under the Affordable Care Act demonstrated an increase in cancer diagnoses, especially early-stage cancer diagnoses, according to study results.

In an updated assessment, the FDA warned against the use of laparoscopic power morcellators for the majority of women undergoing myomectomy or hysterectomy for treatment of uterine fibroids.